Crossmark

Liver targeting of ledipasvir via galactosylated chitosan–coated spanlastics: chemical synthesis, statistical optimization, in vitro, and pharmacokinetic evaluation

Crossref DOI link: https://doi.org/10.1007/s13346-021-00993-8

Published Online: 2021-05-04

Published Print: 2022-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Fatouh, Ahmed M. https://orcid.org/0000-0002-6896-7133
Elshafeey, Ahmed H.

Abdelbary, Ahmed
License Information

Text and Data Mining valid from 2021-05-04

Version of Record valid from 2021-05-04
More Information

Article History

Accepted: 26 April 2021

First Online: 4 May 2021

Declarations

:

: All institutional and national guidelines for the care and use of laboratory animals were followed. The protocol of our pharmacokinetic study was approved by the institutional review board; Research Ethics Committee-Faculty of Pharmacy, Cairo University (REC-FOPCU).

: The authors give the journal of drug delivery and translational research the publication rights for the research article entitled “Liver targeting of ledipasvir via galactosylated chitosan–coated spanlastics: chemical synthesis, Statistical optimization, In-vitro and Pharmacokinetic evaluation.”

: The authors declare no competing interests.

Document is current

Any future updates will be listed below